Cambrex, a global contract development and manufacturing organization, completed the acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. Financial terms were not disclosed. “We are excited to be joining Cambrex, a company with over 40 years of drug substance development and manufacturing expertise. Partnering our best-in-class process development capabilities with Cambrex’s larger scale manufacturing facilities in North America and Europe is a natural fit, both for our employees and our customers," Matt Bio, Snapdragon CEO.